wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38598931-1493C214-749F-4186-BBFE-2BA35319C7BE
Q38598931-1493C214-749F-4186-BBFE-2BA35319C7BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38598931-1493C214-749F-4186-BBFE-2BA35319C7BE
A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France.
P2860
Q38598931-1493C214-749F-4186-BBFE-2BA35319C7BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38598931-1493C214-749F-4186-BBFE-2BA35319C7BE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
65ef9d002efa512f32b084fe47982fb46b862f5c
P2860
PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.